Owing to the high-risk features of his disease (tumor >4 cm and high grade) the patient was enrolled in the ongoing E2805 ASSURE (Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma ...
3don MSN
Cancer researchers are one step closer to developing an effective vaccine to treat people with clear cell renal cell ...
Share and Cite: Hinz, B. and Kenyon, J. (2025) Getting to a Diagnosis: A Rare Case of TFE3 Translocation Renal Cell Carcinoma ...
Researchers evaluated a neoantigen-targeting personalized cancer vaccine in patients with high-risk, fully resected clear ...
The prospective, multicentre, open-label trial is set to begin in the second half of this year to evaluate the drug's safety and anti-tumour activity in adults ... Bio’s renal cell carcinoma ...
Considering taking supplements to treat renal cell carcinoma? Below is a list of common natural remedies used to treat or reduce the symptoms of renal cell carcinoma. Follow the links to read ...
About the Phase 1 Trial The Phase 1 multicenter, open-label clinical trial is designed to investigate ADI-270 as monotherapy in adults with ... About Renal Cell Carcinoma Renal cell carcinoma ...
Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a ...
The FDA has accepted Merck's (MRK) supplemental NDA with priority review for its drug Welireg for the treatment of a rare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback